A tai chi/qigong intervention for older adults living with HIV: a study protocol of an exploratory clinical trial.
A tai chi/qigong intervention for older adults living with HIV: a study protocol of an exploratory clinical trial.
复制标题
DOI:
10.1186/s13063-020-04728-x
复制
发表时间:
2020-09-22
期刊:
影响因子:
2.5
通讯作者:
Lavretsky H
中科院分区:
文献类型:
--
作者:
Ibañez GE;Fennie K;Larkey L;Hu N;Algarin AB;Valdivia C;Lavretsky H
Almost half of people living with HIV (PLWH) in the USA are over 50 years of age; this is expected to increase to 70% by 2020. Yet, few interventions exist for older PLWH that address psychological and physical symptoms combined, both prevalent in this population. There is a need to find innovative and accessible interventions that can help older PLWH to manage their symptoms. Mind-body interventions, like tai chi/qigong (TCQ), improve both physical and psychological health. TCQ is a series of slow, low-impact meditative movements that integrates breathwork, meditation, and stances. The present study is an exploratory clinical trial that will evaluate the acceptability and feasibility of a 12-week, small group TCQ intervention (n = 24), a sham qigong control condition (n = 24), and a standard of care control condition (n = 24) for older people living with HIV/AIDS. It will also explore any preliminary associations between the TCQ intervention and symptom alleviation. Participants will be recruited from community-based health and social services organizations in Miami, FL, and randomized to one of the 3 conditions. We will assess feasibility and acceptability through questionnaires and adherence to TCQ. We will assess preliminary associations with symptoms such as depression, anxiety, social support, chronic HIV-related fatigue, and clinical outcomes. These will be described through proportions, means, and changes over time through graphing techniques. Outcomes will be assessed at baseline, at post-intervention, and at 3 months follow-up. These preliminary analyses also will provide information necessary to estimate effect size and power needed for a larger clinical trial. ClinicalTrials.gov NCT03840525. Registered on 16 July 2018.
登录
查看更多内容
影响因子:
5.9
作者:
McCain, Nancy L.;Gray, D. Patricia;Ketchum, Jessica McKinney
通讯作者:
Ketchum, Jessica McKinney
影响因子:
1.7
作者:
Milanini B;Catella S;Perkovich B;Esmaeili-Firidouni P;Wendelken L;Paul R;Greene M;Ketelle R;Valcour V
通讯作者:
Valcour V
DOI:
10.3402/jchimp.v5.29428
发表时间:
2015-01-01
影响因子:
1
作者:
Harris, Che Matthew;McKenzie, Robin;Kisuule, Flora
通讯作者:
Kisuule, Flora
影响因子:
2.7
作者:
Jahnke, Roger A.;Larkey, Linda K.;Rogers, Carol
通讯作者:
Rogers, Carol
影响因子:
3.6
作者:
Cole, JC;Rabin, AS;Kaufman, AS
通讯作者:
Kaufman, AS